1903P Tumor response by baseline metastases in patients (pts) with renal cell carcinoma (RCC) treated with lenvatinib (L) plus pembrolizumab (P) vs sunitinib (S): Post hoc analysis of the CLEAR trial
| Autor: | Gruenwald, V., McKay, R.R., Buchler, T., Eto, M., Park, S.H., Takagi, T., Zanetta, S., Keizman, D., Rodriguez, C. Suarez, Negrier, S., Lee, J-L., Santini, D., Bedke, J., Staehler, M., Kollmannsberger, C.K., Choueiri, T.K., Motzer, R.J., Burgents, J., Okpara, C.E., Powles, T.B. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S1024-S1025 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|